TARGETING OF LYSYL OXIDASE-LIKE-2 (LOXL2) PROMOTES REVERSAL OF LIVER FIBROSIS VIA INHIBITION OF COLLAGEN CROSS-LINKING AND FIBROTIC MATRIX STABILIZATION

被引:0
|
作者
Ikenaga, N. [1 ]
Yoshida, S. [1 ]
Liu, S. B. [1 ]
Chung, J. [1 ]
Sverdlov, D. [1 ]
Marshall, D. [2 ]
Smith, V. [2 ]
Kovalenko, M. [2 ]
Karnik, S. [2 ]
Afdhal, N. [1 ]
Popov, Y. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
[2] Gilead Sci Inc, Foster City, CA 94404 USA
关键词
D O I
10.1016/S0168-8278(13)60598-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
596
引用
收藏
页码:S243 / S244
页数:2
相关论文
共 46 条
  • [41] Serum Lysyl Oxidase-like 2 (LOXL2) Enzyme Levels Correlate with Fibrosis Stage at Baseline and with Reversibility of Fibrosis in Cirrhotic Patients with Chronic Hepatitis B (CHB) after Treatment with Tenofovir Disoproxil Fumarate (TDF)
    Talal, Andrew
    Lyman, Susan
    Mikels-Vigdal, Amanda
    Adamkewicz, Joanne I.
    Lazarov, Mirella
    Feaster, John M.
    Bornstein, Jeffrey
    Subramanian, Mani
    Smith, Victoria
    McHutchison, John G.
    Ratziu, Vlad
    Friedman, Scott L.
    Afdhal, Nezam
    HEPATOLOGY, 2012, 56 : 263A - 263A
  • [42] Evaluation of the flavonol-rich fraction of Rosa damascena in an animal model of liver fibrosis by targeting the expression of fibrotic cytokines, antioxidant/oxidant ratio and collagen cross-linking
    Rostami, Mehdi
    Aghaei, Mahmoud
    Ghanadian, Mustafa
    Hashemnia, Mohammad
    Moezzi, Nasrin Deilami
    Mohammadalipour, Adel
    LIFE SCIENCES, 2023, 333
  • [43] Minoxidil exerts different inhibitory effects on gene expression of lysyl hydroxylase 1, 2, and 3: Implications for collagen cross-linking and treatment of fibrosis
    Zuurmond, AM
    van der Slot-Verhoeven, AJ
    van Dura, EA
    De Groot, J
    Bank, RA
    MATRIX BIOLOGY, 2005, 24 (04) : 261 - 270
  • [44] Dual combination therapy directed against lysyl oxidase-like 2 (LOXL2) and apoptosis signal-regulating kinase 1 (ASK1) potently inhibits fibrosis and portal hypertension in a new mouse model of PSC-like liver disease
    Ikenaga, Naoki
    Liu, Susan B.
    Peng, Zhen-Wei
    Greenstein, Andrew E.
    French, Dorothy
    Smith, Victoria
    Popov, Yury
    HEPATOLOGY, 2015, 62 : 881A - 881A
  • [45] MiR-4465-modified mesenchymal stem cell-derived small extracellular vesicles inhibit liver fibrosis development via targeting LOXL2 expression
    Wang, Yanjin
    Chen, Yifei
    Yang, Fuji
    Yu, Xiaolong
    Chu, Ying
    Zhou, Jing
    Yan, Yongmin
    Xi, Jianbo
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2024, 25 (07): : 594 - 604
  • [46] Inhibition of lysyl oxidase-like 2 overcomes adhesion-dependent drug resistance in the collagen-enriched liver cancer microenvironment
    Gong, Lanqi
    Zhang, Yu
    Yang, Yuma
    Yan, Qian
    Ren, Jifeng
    Luo, Jie
    Tiu, Yuen Chak
    Fang, Xiaona
    Liu, Beilei
    Lam, Raymond Hiu Wai
    Lam, Ka-On
    Lee, Anne Wing-Mui
    Guan, Xin-Yuan
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (11) : 3194 - 3211